Edition:
India

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

138.44SEK
21 Jun 2018
Change (% chg)

-0.28kr (-0.20%)
Prev Close
138.72kr
Open
138.74kr
Day's High
141.74kr
Day's Low
138.00kr
Volume
155,112
Avg. Vol
153,453
52-wk High
143.86kr
52-wk Low
100.40kr

Latest Key Developments (Source: Significant Developments)

Vitrolife Q1 operating profit rises
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Vitrolife AB ::VITROLIFE AB Q1 SALES AMOUNTED TO SEK 264 (244) MILLION.VITROLIFE AB Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 106 (95) MILLION.  Full Article

Vitrolife buys licensing rights for embryo transfer technology
Thursday, 11 Jan 2018 

Jan 11 (Reuters) - Vitrolife AB ::VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER.SAYS ‍INTENDS TO COMMERCIALISE TECHNOLOGY BY MARKETING A UNIQUE EMBRYO TRANSFER CATHETER​.SAYS ‍INITIAL PURCHASE PRICE AMOUNTED TO USD 5 MILLION​.SAYS ‍ACQUISITION IS EXPECTED TO IMPACT EBITDA PER SHARE MARGINALLY NEGATIVELY DURING 2018-2020 AND POSITIVELY AS FROM 2021​.  Full Article

Vitrolife Q3 core profit rises, like-for-like sales grow 20 pct​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Vitrolife AB :Q3 ‍sales amounted to SEK 246 (210) million, corresponding to an increase of 17 percent in SEK​.Q3 ‍sales growth was 20 percent in local currency and consisted in its entirety of organic growth​.Q3 ‍operating income before depreciation and amortisation (EBITDA) amounted to SEK 98 (71) million, corresponding to a margin of 40 (34) percent​.Says looking ahead, the market outlook is essentially unchanged.  Full Article

Vitrolife Q2 core profit rises, market outlook unchanged
Friday, 15 Jul 2016 

Vitrolife AB : Q2 sales amounted to sek 208 (184) million . Q2 operating income before depreciation and amortisation (ebitda) amounted to sek 74 (62) million, corresponding to a margin of 35 (34) percent. .Says market outlook is essentially unchanged and Vitrolife therefore anticipates a constantly expanding market, which in monetary terms is expected to grow by 5-10 percent per year in the foreseeable future.  Full Article

BRIEF-Vitrolife Q1 operating profit rises

* VITROLIFE AB Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 106 (95) MILLION Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)